| 000 | 01757 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517140155.0 | ||
| 264 | 0 | _c20170911 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1024-2708 | ||
| 024 | 7 |
_a10.12809/hkmj166027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFong, J Ky | |
| 245 | 0 | 0 |
_aAn update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong. _h[electronic resource] |
| 260 |
_bHong Kong medical journal = Xianggang yi xue za zhi _cFeb 2017 |
||
| 300 |
_a74-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcetamides _xtherapeutic use |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aCarbamazepine _xanalogs & derivatives |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 |
_aDrugs, Generic _xtherapeutic use |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aHong Kong |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLacosamide |
| 650 | 0 | 4 | _aLamotrigine |
| 650 | 0 | 4 | _aLevetiracetam |
| 650 | 0 | 4 | _aOxcarbazepine |
| 650 | 0 | 4 |
_aPiracetam _xanalogs & derivatives |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aSocieties, Medical |
| 650 | 0 | 4 |
_aTriazines _xtherapeutic use |
| 700 | 1 | _aChan, E Ly | |
| 700 | 1 | _aLeung, H | |
| 700 | 1 | _aChan, I | |
| 700 | 1 | _aChang, R Sk | |
| 700 | 1 | _aFong, G Cy | |
| 700 | 1 | _aFung, E Lw | |
| 700 | 1 | _aLui, C Ht | |
| 700 | 1 | _aFung, B Bh | |
| 700 | 1 | _aPoon, T L | |
| 700 | 1 | _aSiu, D | |
| 700 | 1 | _aWong, H T | |
| 700 | 1 | _aYeung, E | |
| 700 | 1 | _aYung, A Wy | |
| 700 | 1 | _aZhu, C Xl | |
| 773 | 0 |
_tHong Kong medical journal = Xianggang yi xue za zhi _gvol. 23 _gno. 1 _gp. 74-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.12809/hkmj166027 _zAvailable from publisher's website |
| 999 |
_c26867556 _d26867556 |
||